POLB 001, a p38 MAPK inhibitor, decreases local and systemic inflammatory responses following in vivo LPS administration in healthy volunteers: a randomised, double-blind, placebo-controlled study
POLB 001, a p38 MAPK inhibitor, decreases local and systemic inflammatory responses following in vivo LPS administration in healthy volunteers: a randomised, double-blind, placebo-controlled study
Digna T. de Bruin, Manon A. A. Jansen, Diana R. Pereira, Lisa van Schijndel, Erica S. Klaassen, Marije E. Otto, Jeremy Skillington, Paula Maguire, Liam Tremble, Alan Bell, Laura Maher, Katsuhiro Mihara, Mark Sumeray,...